Glomerular disease related to anti-VEGF therapy.
Stokes
M Barry
MB
Department of Pathology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA. mbs2101@columbia.edu
Erazo
Maria C
MC
D'Agati
Vivette D
VD
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D018270:Carcinoma, Ductal, Breast / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000175:diagnosis; D007678:Kidney Glomerulus / Q000473:pathology; D008875:Middle Aged; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab